Urbanski MJ et al. |
Endocannabinoid-mediated synaptically evoked suppression of GABAergic transmission in the cerebellar cortex. |
2010 |
Neuroscience |
pmid:20553815
|
Dowie MJ et al. |
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. |
2009 |
Neuroscience |
pmid:19524019
|
Straiker A and Mackie K |
Cannabinoid signaling in inhibitory autaptic hippocampal neurons. |
2009 |
Neuroscience |
pmid:19501632
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Sinor AD et al. |
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. |
2000 |
Neurosci. Lett. |
pmid:10653017
|
Sugiura T et al. |
Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. |
2001 |
Neurosci. Lett. |
pmid:11137756
|
Maison P et al. |
BDNF regulates neuronal sensitivity to endocannabinoids. |
2009 |
Neurosci. Lett. |
pmid:19818836
|
Pérez-Morales M et al. |
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation. |
2014 |
Neuroreport |
pmid:25356522
|
Beltramo M and Piomelli D |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. |
2000 |
Neuroreport |
pmid:10817598
|
Covey DP et al. |
Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease. |
2018 |
Neuropsychopharmacology |
pmid:29925886
|
Wills KL et al. |
Double Dissociation of Monoacylglycerol Lipase Inhibition and CB1 Antagonism in the Central Amygdala, Basolateral Amygdala, and the Interoceptive Insular Cortex on the Affective Properties of Acute Naloxone-Precipitated Morphine Withdrawal in Rats. |
2016 |
Neuropsychopharmacology |
pmid:26647976
|
Viganò D et al. |
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. |
2003 |
Neuropsychopharmacology |
pmid:12637958
|
Morena M et al. |
Neurobiological Interactions Between Stress and the Endocannabinoid System. |
2016 |
Neuropsychopharmacology |
pmid:26068727
|
Sumislawski JJ et al. |
Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. |
2011 |
Neuropsychopharmacology |
pmid:21849983
|
Dubreucq S et al. |
Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. |
2012 |
Neuropsychopharmacology |
pmid:22434220
|
Oleson EB et al. |
Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release. |
2014 |
Neuropsychopharmacology |
pmid:24345819
|
Sarchielli P et al. |
Endocannabinoids in chronic migraine: CSF findings suggest a system failure. |
2007 |
Neuropsychopharmacology |
pmid:17119542
|
Blasio A et al. |
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. |
2013 |
Neuropsychopharmacology |
pmid:23793355
|
Maccarrone M et al. |
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. |
2010 |
Neuropsychopharmacology |
pmid:20393458
|
Cristino L et al. |
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signaling Deficiency. |
2016 |
Neuropsychopharmacology |
pmid:26081302
|